Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Apr 26, 2011 (rev. 1)

Premium

Caren Mason has been named CEO and has joined the board of directors of Verinata Health, which recently changed its name from Artemis Health.

Mason has more than 30 years of commercial and diagnostic healthcare experience. Previously, she served as president and CEO of Quidel, a point-of-care, rapid immunoassay diagnostics test company. She also served as CEO of MiraMedica, a company that designs computer-aided detection software to assist radiologists in breast screening, and as CEO of eMed Technologies, a company focused on digital technology for transferring information and images between hospitals and doctors. In addition, she has served as a general manager of the women's healthcare and services business of GE Healthcare and as a senior vice president for Bayer.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.